Is there any maximum standardized uptake value variation among positron emission tomography scanners for mediastinal staging in non-small cell lung cancer?

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 6, 2011, Pages 965-969

  Iskendera, Ilker ^a   Kadioglub, Salih Zeki ^b   Kosarb, Altug ^b   Atasalihib, Ali ^b   Kirb, Altan ^b  

^a Cizre Dr Selahattin Cizrelioglu State Hospital   (Turkey)

^b Sureyyapasa Chest Diseases and Thoracic Surgery Teaching and Research Hospital   (Turkey)

Author keywords

Maximum standardized uptake value; Mediastinoscopy; Non small cell lung cancer; Positron emission tomography predictive ratio; Positron emission tomography integrated computed tomography; Staging

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MEDIASTINUM CANCER; MEDIASTINUM LYMPH NODE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; STANDARDIZED UPTAKE VALUE; THORACOTOMY; VARIANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; EQUIPMENT DESIGN; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINOSCOPY; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; THORACOTOMY; TOMOGRAPHY, X-RAY COMPUTED; TURKEY;

EID: 79958727633     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.258103     Document Type: Article

References (15)

1. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-1723.
2. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-2507.
3. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004;78:1017-1023.
4. Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin Nucl Med 2007;32:607-612.
5. Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, Rusch V. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004;22:3255-3260.
6. Bryant AS, Cerfolio RJ, Klemm KM, Ojha B. Maximum standardized uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer. Ann Thorac Surg 2006;82:417-423.
7. Degirmenci B, Wilson D, Laymon CM, Becker C, Mason NS, Bencherif B, Agarwal A, Luketich J, Landreneau R, Avril N. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PETycomputed tomography. Nucl Med Commun 2008; 29:614-622.
8. Cerfolio RJ, Bryant AS. Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer. Ann Thorac Surg 2007;83:1826-1830.
9. Nabi HA, Zubeldia JM. Clinical applications of F18-FDG in oncology. J Nucl Med Technol 2002;30:3-9.
10. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
11. Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, Kirsch CM. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med 2007;48:1761-1766.
12. Cerfolio RJ, Bryant AS, Ohio B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 2005;130:151-159.
13. Paesmans M, Berghmans T, Dusart M, Garcia C, Hossein-Foucher C, Lafitte JJ, Mascaux C, Meert AP, Roelandts M, Scherpereel A, Terrones Munoz V, Sculier JP. European Lung Cancer Working Party, and on behalf of the IASLC Lung Cancer Staging Project. Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project. J Thorac Oncol 2010;5:612-619.
14. McGee S. Simplifying likelihood ratios. J Gen Intern Med 2002;17:646-649.
15. Tasci E, Tezel C, Orki A, Akin O, Falay O, Kutlu CA. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer. Interact CardioVasc Thorac Surg 2010;10:200-203.